Clinical Trial Update: Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in China evaluating low-dose rt-PA for pulmonary embolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Thromboembolism

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Pulmonary Embolism, Thromboembolism | Phase 4 | Status: COMPLETED